MAIA Biotechnology, Inc. SEC filings MAIA

MAIA Biotechnology, Inc. has 503 filings in SEC EDGAR's recent list, going back to Oct 15, 2021. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

MAIA Biotechnology, Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Oct 7, 2026 —
EFFECT Filing Oct 6, 2026 —
8-K Current report
Regulation FD disclosure
Oct 6, 2026 Oct 6, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
424B3 Prospectus Oct 2, 2026 —
4 Insider transaction Oct 2, 2026 Sep 30, 2026
S-3 Shelf registration Sep 25, 2026 —
4 Insider transaction Sep 15, 2026 Sep 14, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 1, 2026 Aug 26, 2026
EFFECT Filing Aug 28, 2026 —
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 24, 2026 Aug 20, 2026
S-3 Shelf registration Aug 21, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
8-K Current report
Shareholder vote results
May 22, 2026 May 21, 2026
DEFA14A Additional proxy material May 19, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
8-K Current report
Agreement ended
May 14, 2026 May 14, 2026
424B5 Prospectus supplement May 14, 2026 —
10-Q Quarterly report May 11, 2026 Mar 31, 2026
DEFA14A Additional proxy material Apr 27, 2026 —
8-K Current report
Other events
Apr 16, 2026 Apr 16, 2026
4 Insider transaction Apr 14, 2026 Apr 10, 2026
4 Insider transaction Apr 14, 2026 Apr 10, 2026
4 Insider transaction Apr 14, 2026 Apr 10, 2026
8-K Current report
Other events
Apr 8, 2026 Apr 8, 2026
S-8 Employee stock plan registration Apr 7, 2026 —
ARS Annual report to shareholders Apr 7, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 7, 2026 —
DEF 14A Proxy statement Apr 7, 2026 May 21, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Apr 2, 2026 Mar 27, 2026
8-K Current report
Other events
Mar 31, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 27, 2026 Mar 27, 2026
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Material agreement, Other events
Mar 4, 2026 Mar 2, 2026
424B5 Prospectus supplement Mar 4, 2026 —
424B5 Prospectus supplement Mar 2, 2026 —
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
8-K Current report
Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2026 Jan 13, 2026
4 Insider transaction Jan 12, 2026 Sep 19, 2022
D Filing Jan 5, 2026 —
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 17, 2025 Dec 16, 2025
8-K Current report
Other events
Dec 11, 2025 Dec 11, 2025
8-K Current report
Other events
Dec 10, 2025 Dec 10, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 4, 2025 —
4/A Primary document Dec 4, 2025 Nov 25, 2025
4/A Primary document Dec 4, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 28, 2025 Nov 25, 2025
4 Insider transaction Nov 28, 2025 Nov 25, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
8-K Current report
Other events
Nov 21, 2025 Nov 21, 2025
8-K Current report
Other events
Nov 20, 2025 Nov 20, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Other events
Nov 7, 2025 Nov 7, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
8-K Current report
Other events
Oct 24, 2025 Oct 24, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2025 Oct 19, 2025
D Filing Oct 14, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 14, 2025 Oct 13, 2025
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 2, 2025 Oct 1, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 30, 2025 Sep 29, 2025
8-K Current report
Other events
Sep 24, 2025 Sep 24, 2025
8-K Current report
Material agreement, Unregistered share sale
Sep 18, 2025 Sep 18, 2025
8-K Current report
Other events
Sep 12, 2025 Sep 12, 2025
8-K Current report
Other events
Sep 11, 2025 Sep 11, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2025 Sep 7, 2025
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 28, 2025 Jul 28, 2025
8-K Current report
Other events
Jul 17, 2025 Jul 17, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 9, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
8-K Current report
Material agreement, Unregistered share sale
Jun 26, 2025 Jun 24, 2025
8-K Current report
Other events
Jun 24, 2025 Jun 24, 2025
8-K Current report
Other events
Jun 18, 2025 Jun 18, 2025
8-K Current report
Material agreement, Unregistered share sale
Jun 17, 2025 Jun 17, 2025
D Filing Jun 11, 2025 —
4 Insider transaction Jun 5, 2025 Jun 3, 2025
8-K Current report
Other events
Jun 5, 2025 Jun 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 May 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
May 28, 2025 May 27, 2025
8-K Current report
Bylaw or fiscal year change
May 23, 2025 May 22, 2025
8-K Current report
Shareholder vote results, Other events
May 22, 2025 May 22, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
May 6, 2025 May 5, 2025
8-K Current report
Other events
Apr 22, 2025 Apr 22, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 22, 2025
8-K Current report
Other events
Apr 1, 2025 Apr 1, 2025
S-8 Employee stock plan registration Mar 28, 2025 —
PRE 14A Preliminary proxy statement Mar 28, 2025 Mar 28, 2025
8-K Current report
Regulation FD disclosure
Mar 28, 2025 Mar 28, 2025
8-K Current report
Other events
Mar 26, 2025 Mar 26, 2025
424B5 Prospectus supplement Mar 26, 2025 —
8-K Current report
Other events
Mar 21, 2025 Mar 21, 2025
10-K Annual report Mar 21, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 19, 2025 Mar 19, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4/A Primary document Mar 5, 2025 Feb 24, 2025
4/A Primary document Mar 5, 2025 Feb 24, 2025
D Filing Mar 4, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Mar 3, 2025 —
8-K Current report
Other events
Feb 27, 2025 Feb 27, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 25, 2025 Feb 24, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 19, 2025 Feb 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
8-K Current report
Officer or director change
Feb 6, 2025 Feb 1, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 5, 2025 Feb 4, 2025
CORRESP Letter to the SEC Jan 27, 2025 —
UPLOAD Letter from the SEC Jan 22, 2025 —
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
8-K Current report
Other events
Dec 23, 2024 Dec 23, 2024
424B5 Prospectus supplement Dec 23, 2024 —
8-K Current report
Other events
Dec 20, 2024 Dec 16, 2024
4 Insider transaction Dec 13, 2024 Dec 13, 2024
4 Insider transaction Dec 13, 2024 Dec 13, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 10, 2024 Dec 9, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
D Filing Nov 12, 2024 —
8-K Current report
Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
4 Insider transaction Nov 7, 2024 Nov 5, 2024
8-K Current report
Other events
Nov 5, 2024 Nov 5, 2024
4 Insider transaction Nov 4, 2024 Nov 1, 2024
4 Insider transaction Nov 4, 2024 Nov 1, 2024
4 Insider transaction Nov 4, 2024 Nov 1, 2024
4 Insider transaction Nov 4, 2024 Nov 1, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 29, 2024 Oct 28, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MAIA (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chicago, IL
SEC filer status
, Emerging growth company
SEC CIK
1878313

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.